-
Je něco špatně v tomto záznamu ?
Solubility enhancement of piroxicam using different concentrations of the hydrotropic agent sodium benzoate
Rasha Khalid Dhahir
Jazyk angličtina Země Česko
Digitální knihovna NLK
Zdroj
NLK
ROAD: Directory of Open Access Scholarly Resources
od 2011
- MeSH
- benzoát sodný MeSH
- piroxikam * farmakokinetika MeSH
- rozpustnost MeSH
- spektrofotometrie ultrafialová metody MeSH
- techniky in vitro metody MeSH
- uvolňování léčiv MeSH
- výzkum MeSH
Background: Piroxicam is a non-steroidal anti-inflammatory drug, used to alleviate inflammatory signs and symptoms. It is a potent acidic drug that presents mainly in unionized form in the stomach, thus it has a high permeability through the stomach, but poor aqueous solubility. This study, tried to explore the application of hydrotropes to improve the solubility of piroxicam by using different concentrations of the hydrotropic agent sodium benzoate.Methods: Maximum absorbance of piroxicam and its calibration curve was determined using methanol as a solvent, saturated solubility of piroxicam in distilled water and in various concentrations of sodium benzoate 5%, 10%, 15% was measured.Results: The results showed that saturated solubility of piroxicam in aqueous solutions of 5%, 10%, and 15% of sodium benzoate was 19, 53, and 89 time respectively greater than its solubility in distilled water.Conclusion: There was a clear improvement in the solubility of piroxicam with the addition of the hydrotropic agent sodium benzoate, and that solubility increased with more increase in the concentration of the hydrotropic agent.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23007498
- 003
- CZ-PrNML
- 005
- 20230628195845.0
- 007
- ta
- 008
- 230613s2023 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.31482/mmsl.2022.033 $2 doi
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Dhahir, Rasha Khalid $u Department of Pharmaceutics, College of Pharmacy, University of Mosul, Mosul, Iraq
- 245 10
- $a Solubility enhancement of piroxicam using different concentrations of the hydrotropic agent sodium benzoate / $c Rasha Khalid Dhahir
- 520 9_
- $a Background: Piroxicam is a non-steroidal anti-inflammatory drug, used to alleviate inflammatory signs and symptoms. It is a potent acidic drug that presents mainly in unionized form in the stomach, thus it has a high permeability through the stomach, but poor aqueous solubility. This study, tried to explore the application of hydrotropes to improve the solubility of piroxicam by using different concentrations of the hydrotropic agent sodium benzoate.Methods: Maximum absorbance of piroxicam and its calibration curve was determined using methanol as a solvent, saturated solubility of piroxicam in distilled water and in various concentrations of sodium benzoate 5%, 10%, 15% was measured.Results: The results showed that saturated solubility of piroxicam in aqueous solutions of 5%, 10%, and 15% of sodium benzoate was 19, 53, and 89 time respectively greater than its solubility in distilled water.Conclusion: There was a clear improvement in the solubility of piroxicam with the addition of the hydrotropic agent sodium benzoate, and that solubility increased with more increase in the concentration of the hydrotropic agent.
- 650 _7
- $a benzoát sodný $7 D020160 $2 czmesh
- 650 17
- $a piroxikam $x farmakokinetika $7 D010894 $2 czmesh
- 650 _7
- $a uvolňování léčiv $7 D065546 $2 czmesh
- 650 _7
- $a rozpustnost $7 D012995 $2 czmesh
- 650 _7
- $a spektrofotometrie ultrafialová $x metody $7 D013056 $2 czmesh
- 650 _7
- $a výzkum $7 D012106 $2 czmesh
- 650 _7
- $a techniky in vitro $x metody $7 D066298 $2 czmesh
- 773 0_
- $t Vojenské zdravotnické listy $x 0372-7025 $g Roč. 92, č. 2 (2023), s. 159-164 $w MED00011116
- 856 41
- $u https://mmsl.cz/artkey/mms-202302-0009_solubility-enhancement-of-piroxicam-using-different-concentrations-of-the-hydrotropic-agent-sodium-benzoate.php $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3 $c 1073 $y p $z 0
- 990 __
- $a 20230606 $b ABA008
- 991 __
- $a 20230628195839 $b ABA008
- 999 __
- $a ok $b bmc $g 1945732 $s 1193732
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2023 $b 92 $c 2 $d 159-164 $e 20230602 $i 0372-7025 $m Vojenské zdravotnické listy $x MED00011116
- LZP __
- $c NLK183 $d 20230628 $b NLK111 $a Actavia-MED00011116-20230606